BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23651436)

  • 1. Improving resource allocation decisions for health and HIV programmes in South Africa: Bioethical, cost-effectiveness and health diplomacy considerations.
    Kevany S; Benatar SR; Fleischer T
    Glob Public Health; 2013; 8(5):570-87. PubMed ID: 23651436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. South African health care expenditure, 1975-1984.
    Taylor SP; Klopper JM
    S Afr Med J; 1987 Dec; 72(11):802-4. PubMed ID: 3120326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.
    Sulzbach S; De S; Wang W
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i72-84. PubMed ID: 21729920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Strategic Plan of South Africa: what are the prospects of success after the repeated failure of previous AIDS policy?
    Wouters E; van Rensburg HC; Meulemans H
    Health Policy Plan; 2010 May; 25(3):171-85. PubMed ID: 19955092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tackling HIV and gender-based violence in South Africa: how has PEPFAR responded and what are the implications for implementing organizations?
    Ghanotakis E; Mayhew S; Watts C
    Health Policy Plan; 2009 Sep; 24(5):357-66. PubMed ID: 19505995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. South Africa's government's lack-luster AIDS policy.
    AIDS Wkly Plus; 1999 Jun 28-Jul 5; ():9. PubMed ID: 12295209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal access to HIV treatment in developing countries: going beyond the misinterpretations of the 'cost-effectiveness' algorithm.
    Moatti JP; Marlink R; Luchini S; Kazatchkine M
    AIDS; 2008 Jul; 22 Suppl 1():S59-66. PubMed ID: 18664955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public healthcare resource allocation and the Rule of Rescue.
    Cookson R; McCabe C; Tsuchiya A
    J Med Ethics; 2008 Jul; 34(7):540-4. PubMed ID: 18591290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting.
    Cleary S; Mooney G; McIntyre D
    Health Econ; 2010 Oct; 19(10):1166-80. PubMed ID: 19725025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research and reform are priorities for South Africa's new AIDS chiefs.
    Hambridge M
    AIDS Anal Afr; 1995 Jun; 5(3):13. PubMed ID: 12289035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical considerations in resource allocation in a cochlear implant program.
    Westerberg BD; Pijl S; McDonald M
    J Otolaryngol Head Neck Surg; 2008 Apr; 37(2):250-5. PubMed ID: 19128621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the care of people with HIV.
    Goodwin J
    Harv AIDS Rev; 1999; ():16-7. PubMed ID: 12295156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mandela calls for greater commitment and leadership in fighting AIDS. The World Economic Forum -- Policy and business in a world of HIV / AIDS.
    Macinnis R
    AIDSlink; 1997; (43):1, 3. PubMed ID: 12321752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert says AZT could save 40,000 South African children.
    AIDS Wkly; 1999 Nov 29-Dec 6; ():20. PubMed ID: 12349344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allocating funds for HIV/AIDS: a descriptive study of KwaDukuza, South Africa.
    Lasry A; Carter MW; Zaric GS
    Health Policy Plan; 2011 Jan; 26(1):33-42. PubMed ID: 20551138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing efficiency and costs of scaling up HIV treatment.
    Cleary SM; McIntyre D; Boulle AM
    AIDS; 2008 Jul; 22 Suppl 1():S35-42. PubMed ID: 18664951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic and demographic consequences of AIDS in Namibia: rapid assessment of the costs.
    Ojo K; Delaney M
    Int J Health Plann Manage; 1997; 12(4):315-26. PubMed ID: 10177418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.